These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24086261)

  • 1. Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis.
    Gu C; Lu J; Cui T; Lu C; Shi H; Xu W; Yuan X; Yang X; Huang Y; Lu M
    PLoS One; 2013; 8(9):e72633. PubMed ID: 24086261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A meta-analysis of Association between MGMT gene promoter methylation and non-small cell lung cancer].
    Fang N; Gu J; Wei H; You J; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):601-5. PubMed ID: 25130966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.
    Chen B; Ying X; Bao L
    Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma.
    Chen L; Wang Y; Liu F; Xu L; Peng F; Zhao N; Fu B; Zhu Z; Shi Y; Liu J; Wu R; Wang C; Yao S; Li Y
    Sci Rep; 2018 Jan; 8(1):1439. PubMed ID: 29362385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis.
    Gu J; Wen Y; Zhu S; Hua F; Zhao H; Xu H; You J; Sun L; Wang W; Chen J; Zhou Q
    PLoS One; 2013; 8(4):e60107. PubMed ID: 23577085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-6-methylguanine-DNA methyltransferase gene promoter methylation and lung cancer risk: A meta-analysis.
    Yang Z; Li F
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C233-C236. PubMed ID: 28230024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer.
    Ekim M; Caner V; Büyükpınarbaşılı N; Tepeli E; Elmas L; Bağcı G
    Genet Test Mol Biomarkers; 2011 May; 15(5):357-60. PubMed ID: 21288129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data.
    Liu WJ; Tan XH; Guo BP; Ke Q; Sun J; Cen H
    Asian Pac J Cancer Prev; 2013; 14(6):3719-24. PubMed ID: 23886171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer].
    Wei H; Fang N; Guo L; Wu Z; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis.
    Yuan X; Xu J; Fang W; Zhao Z; Wang F; Tong Z
    Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome.
    Brabender J; Usadel H; Metzger R; Schneider PM; Park J; Salonga D; Tsao-Wei DD; Groshen S; Lord RV; Takebe N; Schneider S; Hölscher AH; Danenberg KD; Danenberg PV
    Clin Cancer Res; 2003 Jan; 9(1):223-7. PubMed ID: 12538473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
    Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
    PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.
    Wolf P; Hu YC; Doffek K; Sidransky D; Ahrendt SA
    Cancer Res; 2001 Nov; 61(22):8113-7. PubMed ID: 11719438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer.
    Hua F; Fang N; Li X; Zhu S; Zhang W; Gu J
    PLoS One; 2014; 9(5):e96163. PubMed ID: 24796328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
    Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.
    Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD
    Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis.
    Cai F; Xiao X; Niu X; Shi H; Zhong Y
    PLoS One; 2016; 11(9):e0163534. PubMed ID: 27657735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis.
    Hu B; Zhang H; Wei H; Wang Z; Zhang F; Wang X; Li L
    Thorac Cancer; 2017 Sep; 8(5):410-416. PubMed ID: 28497891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
    Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
    Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.